Index/VIPImmune & Thymic

VIP

Vasoactive Intestinal Peptide · VIP peptide

Neuropeptide — immune regulation, anti-inflammation, and pulmonary health.

FDA

Research Only

WADA

Not Listed

HALF-LIFE

~1–2 minutes (IV), ~30 min (inhaled)

ROUTE

Intranasal or inhaled

SCHEDULE

2–4× daily

In Plain English

Neuropeptide — immune regulation, anti-inflammation, and pulmonary health.

Status & Legality

What do these mean?

NATTY?

?
No Test Exists

No established test exists for this compound.

FDA

?
Research Only

For research purposes only. Not FDA approved.

WADA

?
Not Listed

Not currently on WADA prohibited list.

COMPOUNDING

?
Not from pharmacies

Not available from licensed compounding pharmacies.

PRESCRIBED

?
Not prescribed

Not prescribed in conventional medicine.

ROUTE

?
Intranasal or inhaled

Administration via intranasal or inhaled.

Who It's For

Immune modulation

Pulmonary hypertension

Anti-inflammatory

CIRS/mold illness

How It Works

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide with potent anti-inflammatory, bronchodilating, and immune-regulatory effects. It's widely used in treatment of Chronic Inflammatory Response Syndrome (CIRS), mold illness, and as an adjunct in pulmonary hypertension. Dr. Shoemaker's CIRS protocol uses VIP nasal spray as a final step.

Side Effects

01

Flushing (inhaled)

02

Transient hypotension

03

Headache

04

Rare: rapid heart rate

Common Mistakes

Using VIP prematurely in CIRS protocols — VIP is the final step after biotoxin burden is reduced; using too early causes symptom worsening, not improvement

Not having freshly compounded preparations — VIP degrades quickly; preparations more than a few weeks old lose potency

Using in patients still actively exposed to mold — won't work and may exacerbate symptoms if the biotoxin source hasn't been removed

Drug & Supplement Interactions

Vasodilators — additive hypotensive effects; monitor blood pressure carefully

Anticholinergics — may reduce VIP's bronchodilating effects

Immunomodulatory compounds — generally synergistic in late-stage CIRS protocols

The PepVault Take

VIP is a last-step CIRS compound in the Shoemaker protocol — not a first-line treatment. Using it out of sequence, before removing mold exposure and reducing biotoxin burden, reliably worsens CIRS symptoms. In the correct sequence, it produces some of the most dramatic improvements in CIRS patients of any single intervention.

Frequently Asked Questions

Similar & Complementary

Free, no account needed

New to VIP? Grab the starter checklist.

Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.

No spam, and we never sell your email. Just the checklist. Email support@pepvault.us to opt out any time.

Common questions about VIP

Stats

ONSET50
DOCUMENTATION18
SIDE INTENSITY49
CYCLE EASE70
POPULARITY25
Add to My Stack

Sources & Studies

1/2
Research Use OnlyNot Medical AdviceNot FDA Evaluated18+ OnlyWADA Status Tracked

PepVault provides educational and research reference information only. Nothing on this site constitutes medical advice, diagnosis, or treatment. Content has not been evaluated by the U.S. Food and Drug Administration. No compound listed on this site is intended to diagnose, treat, cure, or prevent any disease or medical condition. The legality of peptide compounds varies by jurisdiction — you are solely responsible for compliance with the laws of your country or region. Certain compounds listed are prohibited under the World Anti-Doping Agency (WADA) Prohibited List; athletes subject to anti-doping regulations should independently verify status before use. This site is intended for adults 18 years of age or older. Always consult a licensed healthcare provider before using any compound.

© 2026 PepVault. All rights reserved.